C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 116 filers reported holding C4 THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $126,753 | -81.2% | 68,147 | -72.2% | 0.00% | -75.0% |
| Q2 2023 | $674,306 | +1374.9% | 245,202 | +1584.1% | 0.00% | – |
| Q1 2023 | $45,718 | -82.8% | 14,560 | -67.7% | 0.00% | -100.0% |
| Q4 2022 | $266,090 | -64.7% | 45,100 | -47.5% | 0.00% | -50.0% |
| Q3 2022 | $753,000 | -17.6% | 85,908 | -29.1% | 0.00% | -33.3% |
| Q2 2022 | $914,000 | -3.5% | 121,218 | +210.6% | 0.01% | -25.0% |
| Q1 2022 | $947,000 | -13.5% | 39,024 | +14.8% | 0.01% | -20.0% |
| Q4 2021 | $1,095,000 | -34.3% | 33,997 | -8.9% | 0.01% | -52.4% |
| Q3 2021 | $1,667,000 | +353.0% | 37,300 | +283.2% | 0.02% | +425.0% |
| Q2 2021 | $368,000 | -44.4% | 9,733 | -51.3% | 0.00% | -55.6% |
| Q4 2020 | $662,000 | – | 19,994 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,642,210 | $39,840,000 | 3.87% |
| Paradigm Biocapital Advisors LP | 499,496 | $12,118,000 | 3.20% |
| Cypress Point Wealth Management, LLC | 118,573 | $2,877,000 | 2.92% |
| COMMODORE CAPITAL LP | 481,094 | $11,671,000 | 2.61% |
| Nextech Invest Ltd. | 375,857 | $9,118,000 | 2.60% |
| RTW INVESTMENTS, LP | 4,531,982 | $109,946,000 | 2.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 362,528 | $8,795,000 | 1.24% |
| Perceptive Advisors | 2,082,723 | $50,526,000 | 1.01% |
| CLOUGH CAPITAL PARTNERS L P | 356,181 | $8,641,000 | 0.66% |
| HighVista Strategies LLC | 34,760 | $843,000 | 0.54% |